The role of pre-existing cross-reactive antibodies in determining the efficacy of vaccination in humans: study protocol for a randomized controlled trial

被引：0
|
作者：
Jenny G Low
Limin Wijaya
Greg KY Li
Eleanor YL Lim
Aland KL Shum
Yin-Bun Cheung
Eng-Eong Ooi
机构：
[1] Singapore General Hospital,Department of Infectious Diseases
[2] Singapore General Hospital,Singhealth Investigational Medicine Unit
[3] Duke-NUS Graduate Medical School,Centre for Quantitative Medicine
[4] Duke-NUS Graduate Medical School,Program in Emerging Infectious Diseases
来源：
Trials | / 16卷
关键词：
Live vaccination; Cross-reactive neutralizing antibodies; Innate immune response; Adaptive immune response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The role of pre-existing cross-reactive antibodies in determining the efficacy of vaccination in humans: study protocol for a randomized controlled trial
    Low, Jenny G.
    Wijaya, Limin
    Li, Greg K. Y.
    Lim, Eleanor Y. L.
    Shum, Aland K. L.
    Cheung, Yin-Bun
    Ooi, Eng-Eong
    TRIALS, 2015, 16
  • [2] Cross-reactive and pre-existing antibodies to therapeutic antibodies-Effects on treatment and immunogenicity
    van Schie, Karin A.
    Wolbink, Gerrit-Jan
    Rispens, Theo
    MABS, 2015, 7 (04) : 662 - 671
  • [3] Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity
    Henze, Larissa
    Braun, Julian
    Meyer-Arndt, Lil
    Juerchott, Karsten
    Schlotz, Maike
    Michel, Janine
    Grossegesse, Marica
    Mangold, Maike
    Dingeldey, Manuela
    Kruse, Beate
    Holenya, Pavlo
    Mages, Norbert
    Reimer, Ulf
    Eckey, Maren
    Schnatbaum, Karsten
    Wenschuh, Holger
    Timmermann, Bernd
    Klein, Florian
    Nitsche, Andreas
    Giesecke-Thiel, Claudia
    Loyal, Lucie
    Thiel, Andreas
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [4] Primary ChAdOx1 vaccination fails to reactivate pre-existing, cross-reactive T cells
    Henze, L.
    Braun, J.
    Meyer-Arndt, L.
    Juerchott, K.
    Schlotz, M.
    Michel, J.
    Grossegesse, M.
    Mangold, M.
    Dingeldey, M.
    Kruse, B.
    Holenya, P.
    Mages, N.
    Reimer, U.
    Eckey, M.
    Timmermann, B.
    Klein, F.
    Nitsche, A.
    Giesecke-Thiel, C.
    Loyal, L.
    Thiel, A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 : 74 - 74
  • [5] Impact of pre-existing cross-reactive antibodies on cyclic dengue outbreaks in the hyperendemic region of Bali, Indonesia
    Balingit, Jean Claude
    Denis, Dionisius
    Suzuki, Ryosuke
    Hayati, Rahma Fitri
    Tun, Mya Myat Ngwe
    Takamatsu, Yuki
    Masyeni, Sri
    Sasmono, R. Tedjo
    Morita, Kouichi
    VIRUS RESEARCH, 2024, 348
  • [6] The Role of Pre-existing Cross-Reactive Central Memory CD4 T-Cells in Vaccination With Previously Unseen Influenza Strains
    Nienen, Mikalai
    Stervbo, Ulrik
    Moelder, Felix
    Kaliszczyk, Sviatlana
    Kuchenbecker, Leon
    Gayova, Ludmila
    Schweiger, Brunhilde
    Juerchott, Karsten
    Hecht, Jochen
    Neumann, Avidan U.
    Rahmann, Sven
    Westhoff, Timm
    Reinke, Petra
    Thiel, Andreas
    Babel, Nina
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [7] Evidence and implications of pre-existing humoral cross-reactive immunity to SARS-CoV-2
    Mveang Nzoghe, Amandine
    Essone, Paulin N.
    Leboueny, Marielle
    Maloupazoa Siawaya, Anicet Christel
    Bongho, Eliode Cyrien
    Mvoundza Ndjindji, Ofilia
    Avome Houechenou, Rotimi Myrabelle
    Agnandji, Selidji Todagbe
    Djoba Siawaya, Joel Fleury
    IMMUNITY INFLAMMATION AND DISEASE, 2021, 9 (01) : 128 - 133
  • [8] A possible role of pre-existing IgM/IgG antibodies in determining immune response type
    Seledtsov, VI
    Seledtsova, GV
    IMMUNOLOGY AND CELL BIOLOGY, 1997, 75 (02): : 176 - 180
  • [9] The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
    Murray, Sam M. M.
    Ansari, Azim M. M.
    Frater, John
    Klenerman, Paul
    Dunachie, Susanna
    Barnes, Eleanor
    Ogbe, Ane
    NATURE REVIEWS IMMUNOLOGY, 2023, 23 (05) : 304 - 316
  • [10] The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
    Sam M. Murray
    Azim M. Ansari
    John Frater
    Paul Klenerman
    Susanna Dunachie
    Eleanor Barnes
    Ane Ogbe
    Nature Reviews Immunology, 2023, 23 : 304 - 316
12345